Table 1.
Characteristics of Participants.
| AF Group (n = 17) |
No AF Group (n = 17) |
p Value | |
|---|---|---|---|
| Age-Years (mean ± SD) | 73 ± 7 | 74 ± 7 | 0.60 |
| Male Sex-n (%) | 11 (64.7) | 9 (52.9) | 0.69 |
| BMI-kg/m2 (Median (IQR)) | 24.9 (23.0–29.2) | 25.3 (22.9–29.1) | 0.16 |
| Underlying Heart Disease-n (%) | 1.00 | ||
| IHD | 2 (11.8) | 2 (11.8) | |
| (i)VHD | 15 (88.2) | 15 (88.2) | |
| AVD | 2 (11.8) | 3 (17.6) | |
| AVD and CAD | 2 (11.8) | 2 (11.8) | |
| MVD | 9 (52.9) | 7 (41.2) | |
| MVD and CAD | 2 (11.8) | 3 (17.6) | |
| Echocardiography | |||
| LVF-n (%) | 1.00 | ||
| Normal | 11 (64.7) | 12 (70.6) | |
| Mild dysfunction | 3 (17.6) | 2 (11.8) | |
| Moderate dysfunction | 3 (17.6) | 3 (17.6) | |
| Severe dysfunction | 0 (0.0) | 0 (0.0) | |
| Dilated LA >45 mm-n (%) | 11/13 (84.6) | 9/15 (60.0) | 0.41 |
| Medication-n (%) | |||
| Antiarrhythmic Drugs | 0.45 | ||
| Class I | 0 (0.0) | 0 (0.0) | |
| Class II | 11 (64.7) | 7 (41.2) | |
| Class III | 4 (23.5) | 0 (0.0) | |
| Class IV | 1 (5.9) | 1 (5.9) | |
| Digoxin | 5 (29.4) | 0 (0.0) | 0.06 |
n = number; SD = standard deviation; AF = atrial fibrillation; AVD = aortic valve disease; BMI = Body Mass Index; CAD = coronary artery disease; IHD = ischemic heart disease; LA = left atrium; LVF = left ventricular function; MVD = mitral valve disease; (i)VHD = (ischemic and) valvular heart disease.